Abstract
Ketamine, a noncompetitive NMDA receptor antagonist, has potent psychomimetic effects, being able to accentuate the psychotic state of schizophrenic patients. One of the brain areas affected by its use is the prefrontal cortex, as the performance on tasks dependent upon their activity is deeply influenced by the acute administration of ketamine. As in schizophrenia, these changes may be m…